| Literature DB >> 18215251 |
Manijeh Vafa1, Marita Troye-Blomberg, Judith Anchang, André Garcia, Florence Migot-Nabias.
Abstract
BACKGROUND: Individuals living in malaria endemic areas generally harbour multiple parasite strains. Multiplicity of infection (MOI) can be an indicator of immune status. However, whether this is good or bad for the development of immunity to malaria, is still a matter of debate. This study aimed to examine the MOI in asymptomatic children between two and ten years of age and to relate it to erythrocyte variants, clinical attacks, transmission levels and other parasitological indexes.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18215251 PMCID: PMC2267475 DOI: 10.1186/1475-2875-7-17
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Parasitological indexes before and after transmission season
| June 2002 | January 2003 | ||
| Age-range (years) | 2–10 | 2–10 | |
| Mean age ± SD | 5.0 ± 1.6 | 5.6 ± 1.6 | |
| Sex ratio (M/F) | 1.1 (195/177) | 1.1 (195/177) | |
| Parasite prevalencea (%) | |||
| Microscopy | 35 | 35 | |
| PCR | 44 | 51 | NS |
| Parasite densityb | 2.9 | 7.6 | 0.01 |
| Parasite density 25th–75th percentiles | 0.8–11.2 | 1.3–33.1 | |
| MOIc (mean) | 2.5 | 4.1 | 0.0001 |
| MOI (range) | 1–7 | 1–10 | |
| Number of subjects | 372 | 372 | |
a Proportion of infected individuals.
b P. falciparum density (parasites/100 leukocytes)-median, zero values excluded.
c Number of clones identified as msp2 alleles, excluding PCR negatives.
Infection prevalence and MOI in subjects stratified by blood groups and haemoglobinopathies before and after the transmission season
| June 2002 | January 2003 | ||||
| Whole groupa n (%) | nb (%) | MOI; mean (range) | nb (%) | MOI; mean (range) | |
| Blood group | |||||
| O | 193 (52) | 81/193 (42) | 2.6 (1 – 7) | 99/193 (51) | 4.1 (1–10)g*** |
| A | 100 (27) | 47/100 (47) | 2.6 (1 – 7) | 50/100 (50) | 4.0 (1 – 9)g** |
| B | 69 (18) | 34/69 (49) | 2.3 (1 – 6) | 32/69 (46) | 4.2 (1 – 10)g* |
| AB | 10 (3) | 2/10 (20) | 4.0 (1 – 7) | 7/10 (70) | 4.6 (2 – 8)g* |
| Hemoglobin | |||||
| AA | 319 (86) | 144/319 (45) | 2.5 (1 – 7) | 162/319 (51) | 4.0 (1–10)g*** |
| AS | 51 (14) | 19/51 (37) | 2.7 (1 – 5) | 26/51 (51) | 4.5 (1 – 10)g** |
| α+-thalassemiaC | |||||
| Normal | 234 (76) | 103/234 (44) | 2.3 (1 – 7) | 118/234 (50) | 3.9 (1–10)g*** |
| Mutation | 75 (24) | 37/75 (49) | 2.8 (1 – 7) | 36/75 (48) | 4.1 (1 – 9) |
| G6PD in femalesd | |||||
| Normal | 141 (81) | 60/141 (43) | 2.7 (1 – 7) | 73/141 (52)f | 4.4 (1 – 10)g** |
| Mutation | 34 (19) | 11/34 (32) | 2.7 (1 – 4) | 9/34 (26) | 4.6 (1 – 10) |
| G6PD in malese | |||||
| Normal | 166 (87) | 77/166 (46) | 2.5 (1 – 7) | 90/166 (54) | 3.8 (1–10)g*** |
| Mutation | 24 (13) | 14/24 (58) | 1.7 (1 – 4) | 14/24 (58) | 3.4 (1 – 7) |
a Total number of samples = 372, missing values for hemoglobin (n = 2), α+-thalassemia (n = 63) and G6PD (n = 7).
b Proportion of infected individuals to total.
c Mutation indicated in both heterozygous and homozygous state.
d G6PD mutations include G6PD A-/B, A-/A heterozygous and A-/A- homozygous genotypes.
e G6PD mutation corresponds to A- hemizygous genotype.
f Significantly less infection prevalence in G6PD mutated girls as compared to normal ones; χ2-test, P < 0.01.
g Wilcoxon signed rank test for the comparison of MOI in June and January;
* P < 0.05
** P < 0.01
*** P < 0.0001
Figure 1Parasite prevalence (A) and densities (B) amongst girls carrying G6PD A- or G6PD A-/HbAS variants. Parasite prevalence was defined as the percentage (CI 95%) of infected subjects detected by PCR. Parasite densities were compared as median (25th–75th percentiles) excluding zero values.
Figure 2Parasite prevalence (A) and densities (B) amongst boys carrying G6PD A- or G6PD A-/HbAS variants. Parasite prevalence was defined as the percentage (CI 95%) of infected subjects detected by PCR. Parasite densities were compared as median (25th–75th percentiles) excluding zero values.